Cookies?
Library Header Image
LSE Research Online LSE Library Services

Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study

Haro, Josep Maria and Lamy, François-Xavier and Jönsson, Bengt and Knapp, Martin and Brignone, Mélanie and Caillou, Hugo and Chalem, Ylana and Hammer-Helmich, Lene and Rive, Benoît and Saragoussi, Delphine (2018) Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study. BMC Psychiatry. ISSN 1471-244X

[img]
Preview
Text - Published Version
Available under License Creative Commons Attribution.

Download (698kB) | Preview

Identification Number: 10.1186/s12888-018-1657-3

Abstract

Background Patients who require a switch in their antidepressant therapy may have different clinical profiles and treatment needs compared with patients initiating or maintaining a first-line antidepressant therapy. Methods The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (MDD) (PERFORM) study was a 2-year observational cohort study in outpatients with MDD in five European countries. Enrolled patients were either initiating or undergoing the first switch to an antidepressant monotherapy. Baseline data on patients’ clinical status, functioning, productivity, quality of life and medical-resource use were compared in a cross-sectional baseline analysis. Results A total of 1402 patients were enrolled, of whom 1159 (82.7%) provided analysable baseline data. The majority (78.7%) of the analysable population were initiating antidepressant treatment and most (83.6%) were enrolled and followed up by general practitioners. Compared with patients initiating antidepressants, those switching antidepressants (21.3%) tended to have more severe depressive symptoms, greater anxiety, worse health-related quality of life, greater functional impairment, greater medical-resource use and had a different medical history. Limitations included an over-representation of switches due to lack of efficacy among patients who were switching treatment, as patients were selected based on presence of depressive symptoms. Conclusions Patients with MDD who are switching treatment for the first time have a different profile and different depression-associated health needs compared with those initiating treatment. Therapeutic management should therefore be adapted for patients who switch.

Item Type: Article
Official URL: https://bmcpsychiatry.biomedcentral.com/
Additional Information: © 2018 The Author(s)
Divisions: Social Policy
Personal Social Services Research Unit
Subjects: B Philosophy. Psychology. Religion > BF Psychology
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Sets: Departments > Social Policy
Research centres and groups > Personal Social Services Research Unit (PSSRU)
Date Deposited: 09 May 2018 09:46
Last Modified: 09 May 2018 09:55
URI: http://eprints.lse.ac.uk/id/eprint/87810

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics